These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38029491)

  • 1. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
    El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
    J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.
    Wang L; Wang Y; Fan X; Tang W; Hu J
    Medicine (Baltimore); 2015 Nov; 94(45):e1931. PubMed ID: 26559260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study.
    Chumbita M; Puerta-Alcalde P; Yáñez L; Cuesta MA; Chinea A; Español Morales I; Fernández Abellán P; Gudiol C; Guerreiro M; González-Sierra P; Rojas R; Sánchez Pina JM; Sánchez Vadillo I; Varela R; Vázquez L; Lopera C; Monzó P; Garcia-Vidal C
    J Antimicrob Chemother; 2022 Jun; 77(7):2017-2023. PubMed ID: 35466357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis.
    Lopera C; Monzó P; Aiello TF; Chumbita M; Peyrony O; Gallardo-Pizarro A; Pitart C; Cuervo G; Morata L; Bodro M; Herrera S; Del Río A; Martínez JA; Soriano A; Puerta-Alcalde P; Garcia-Vidal C
    Microbiol Spectr; 2024 Oct; 12(10):e0296123. PubMed ID: 39194256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection.
    Di Domenico EG; Marchesi F; Cavallo I; Toma L; Sivori F; Papa E; Spadea A; Cafarella G; Terrenato I; Prignano G; Pimpinelli F; Mastrofrancesco A; D'Agosto G; Trento E; Morrone A; Mengarelli A; Ensoli F
    Microbiol Spectr; 2021 Sep; 9(1):e0055021. PubMed ID: 34406812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
    Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
    J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
    Chen CY; Tang JL; Hsueh PR; Yao M; Huang SY; Chen YC; Chen YC; Shen MC; Wang CH; Tsai W; Chang SC; Tien HF; Luh KT
    J Formos Med Assoc; 2004 Jul; 103(7):526-32. PubMed ID: 15318274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia.
    Schonardie AP; Beck E; Rigatto MH
    Braz J Infect Dis; 2023; 27(2):102758. PubMed ID: 36809849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bloodstream infections in neutropenic patients with haematological malignancies.
    Carvalho AS; Lagana D; Catford J; Shaw D; Bak N
    Infect Dis Health; 2020 Feb; 25(1):22-29. PubMed ID: 31586572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies.
    Puerta-Alcalde P; Cardozo C; Suárez-Lledó M; Rodríguez-Núñez O; Morata L; Fehér C; Marco F; Del Río A; Martínez JA; Mensa J; Rovira M; Esteve J; Soriano A; Garcia-Vidal C
    Clin Microbiol Infect; 2019 Apr; 25(4):447-453. PubMed ID: 30096417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
    Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
    Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
    Chong Y; Shimoda S; Yakushiji H; Ito Y; Miyamoto T; Kamimura T; Shimono N; Akashi K
    PLoS One; 2013; 8(1):e54190. PubMed ID: 23372683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
    Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
    BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia.
    Ben-Chetrit E; Eldaim MA; Bar-Meir M; Dodin M; Katz DE
    Int J Antimicrob Agents; 2019 Apr; 53(4):423-428. PubMed ID: 30572008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
    Khoo AL; Zhao YJ; Teng M; Ying D; Jin J; Chee YL; Poon LM; Lim SE; Koh LP; Chng WJ; Lim BP; Hsu LY; Chai LYA
    Int J Antimicrob Agents; 2018 Sep; 52(3):350-357. PubMed ID: 29751120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.
    Trecarichi EM; Giuliano G; Cattaneo C; Ballanti S; Criscuolo M; Candoni A; Marchesi F; Laurino M; Dargenio M; Fanci R; Cefalo M; Delia M; Spolzino A; Maracci L; Bonuomo V; Busca A; Principe MID; Daffini R; Simonetti E; Dragonetti G; Zannier ME; Pagano L; Tumbarello M;
    Int J Antimicrob Agents; 2023 Jun; 61(6):106806. PubMed ID: 37030470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis.
    Raad C; Behdenna A; Fuhrmann C; Conter C; Cuzzubbo D; Rasigade JP; Bertrand Y; Domenech C
    Eur J Pediatr; 2021 Sep; 180(9):2921-2930. PubMed ID: 33835249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations.
    Chumbita M; Puerta-Alcalde P; Yáñez L; Angeles Cuesta M; Chinea A; Español-Morales I; Fernandez-Abellán P; Gudiol C; González-Sierra P; Rojas R; Sánchez-Pina JM; Vadillo IS; Sánchez M; Varela R; Vázquez L; Guerreiro M; Monzo P; Lopera C; Aiello TF; Peyrony O; Soriano A; Garcia-Vidal C
    Microbiol Spectr; 2023 Aug; 11(4):e0067423. PubMed ID: 37367629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study.
    Irfan S; Idrees F; Mehraj V; Habib F; Adil S; Hasan R
    BMC Infect Dis; 2008 Jun; 8():80. PubMed ID: 18541017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.